World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
93
Citations
41584
World Ranking
10716
National Ranking
5510

Overview

John Seibyl is affiliated with Yale University in the United States. Their research is situated primarily in the field of Medicine, with a focus on Neurology, Radiology, Nuclear Medicine and Imaging, Physiology, Cellular and Molecular Neuroscience, and Cognitive Neuroscience. The main topics covered by their work include Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Alzheimer's disease research and treatments, Genetics and Neurodevelopmental Disorders, Advanced Neuroimaging Techniques and Applications, Dementia and Cognitive Impairment Research, and Medical Imaging Techniques and Applications.

The scientist has published numerous articles in notable venues. Some of the frequent publication venues include:

  • Zenodo (CERN European Organization for Nuclear Research)
  • Journal of Nuclear Medicine
  • Alzheimer s & Dementia
  • European Journal of Nuclear Medicine and Molecular Imaging
  • Movement Disorders

Seibyl often collaborates with a consistent group of coauthors. Frequent co-authors include Kenneth Marek, David Russell, Osama Sabri, Olivier Barret, and Henryk Barthel.

Significant recent papers authored or co-authored by Seibyl encompass:

  • Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study, 2023, The Lancet Neurology
  • A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research, 2024, The Lancet Neurology
  • Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy, 2020, JAMA Neurology
  • EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0, 2020, European Journal of Nuclear Medicine and Molecular Imaging
  • Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression, 2020, Movement Disorders

Best Publications

  • Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.

    John H. Krystal;Laurence P. Karper;John P. Seibyl;Glenna K. Freeman

  • MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder.

    J. Douglas Bremner;Penny Randall;Tammy M. Scott;Richard A. Bronen

  • The Parkinson Progression Marker Initiative (PPMI)

    Kenneth Marek;Danna Jennings;Shirley Lasch;Andrew Siderowf

  • Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

    M Laruelle;A Abi-Dargham;C H van Dyck;R Gil

  • Pramipexole vs Levodopa as initial treatment for Parkinson disease: A randomized controlled trial

    R. Holloway;I. Shoulson;K. Kieburtz;M. McDermott

  • Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort.

    Abi-Dargham A;Gil R;Krystal J;Baldwin Rm

  • CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts

    Oskar Hansson;John Seibyl;Erik Stomrud;Henrik Zetterberg

  • Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.

    Robert G Holloway;Ira Shoulson;Stanley Fahn;Karl Kieburtz

  • Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study

    Henryk Barthel;Hermann-Josef Gertz;Stefan Dresel;Oliver Peters

  • The Parkinson's progression markers initiative (PPMI): establishing a PD biomarker cohort

    Kenneth Marek;Sohini Chowdhury;Andrew Siderowf;Shirley Lasch

  • Reduced brain serotonin transporter availability in major depression as measured by [123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computed tomography

    Robert T Malison;Lawrence H Price;Robert Berman;Christopher H van Dyck

  • Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease.

    J. P. Seibyl;K. L. Marchek;D. Quinlan;K. Sheff

  • Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study

    Osama Sabri;Marwan N. Sabbagh;John Seibyl;Henryk Barthel

  • Performance Characteristics of Amyloid PET with Florbetapir F 18 in Patients with Alzheimer's Disease and Cognitively Normal Subjects

    Abhinay D. Joshi;Michael J. Pontecorvo;Chrisopher M. Clark;Alan P. Carpenter

  • [sup 123 I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease

    K. L. Marek;J. P. Seibyl;S. S. Zoghbi;Y. Zea-Ponce

  • Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease.

    R B Innis;J P Seibyl;B E Scanley;M Laruelle

  • [123I]β-CIT SPECT imaging assessment of the rate of Parkinson’s disease progression

    K. Marek;R. Innis;C. van Dyck;B. Fussell

  • Clinical significance of neurological soft signs in schizophrenia: Factor analysis of the Neurological Evaluation Scale

    R. Andrew Sewell;Edward B. Perry;Laurence P. Karper;Morris D. Bell

  • Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau181, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson Disease

    Ju-Hee Kang;Ju-Hee Kang;David J. Irwin;Alice S. Chen-Plotkin;Andrew Siderowf

  • The role of radiotracer imaging in Parkinson disease

    B. Ravina;D. Eidelberg;J. E. Ahlskog;R. L. Albin

Frequent Co-Authors

Kenneth Marek
Kenneth Marek Institute for Neurodegenerative Disorders
Gilles Tamagnan
Gilles Tamagnan Yale University
Robert B. Innis
Robert B. Innis National Institutes of Health
Danna Jennings
Danna Jennings Denali Therapeutics (United States)
Henryk Barthel
Henryk Barthel Leipzig University
Dennis S. Charney
Dennis S. Charney Icahn School of Medicine at Mount Sinai
Kelly P. Cosgrove
Kelly P. Cosgrove Yale University
John H. Krystal
John H. Krystal Yale University
Robert T. Malison
Robert T. Malison Yale University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As you explore medical education in the USA, it’s important to consider flexible online routes that can expand your career options. For those interested in nursing, affordable nursing programs can help minimize student debt while providing a solid foundation for future healthcare roles.

Career advancement often requires ongoing education. Earning your doctorate through online phd nursing programs can boost your qualifications for leadership, research, and academic positions, all while maintaining professional flexibility.

Registered Nurses seeking more responsibility and higher earning potential can benefit from the cheapest online rn to bsn programs. These accelerated pathways can help you advance quickly and conveniently.

If you hold a non-nursing degree but want to move into the field, direct msn programs online offer a fast-track entry point. These programs are designed for career changers eager to pursue nursing at an advanced level.

Researching these online degrees can help you find affordable, reputable programs that align with your goals—and put you on a successful healthcare career path.

Best Scientists Citing John Seibyl

Trending Scientists

Recently Published Articles